REGN:NGS-Regeneron Pharmaceuticals Inc. (USD)

EQUITY | Biotechnology | Nasdaq Global Select

Last Closing

USD 1199.29

Change

-2.47 (-0.21)%

Market Cap

USD 42.08B

Volume

0.31M

Analyst Target

USD 674.63
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Regeneron Pharmaceuticals Inc is a fully integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-28 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
VRTX Vertex Pharmaceuticals Inc

+6.72 (+1.40%)

USD 123.52B
ALNY Alnylam Pharmaceuticals Inc

+3.54 (+1.35%)

USD 33.60B
ARGX argenx NV ADR

+2.24 (+0.42%)

USD 32.41B
MRNA Moderna Inc

-1.40 (-2.01%)

USD 28.23B
BGNE BeiGene Ltd

+2.22 (+1.13%)

USD 20.54B
BMRN Biomarin Pharmaceutical Inc

+0.52 (+0.62%)

USD 17.44B
RPRX Royalty Pharma Plc

+0.17 (+0.62%)

USD 17.14B
UTHR United Therapeutics Corporatio..

-1.99 (-0.58%)

USD 15.72B
PCVX Vaxcyte Inc

+1.87 (+1.64%)

USD 14.27B
INSM Insmed Inc

+0.75 (+1.01%)

USD 12.93B

ETFs Containing REGN

FPXU:PA First Trust US Equity Opp.. 9.38 % 0.00 %

+0.85 (+1.41%)

USD 6.68M
CURG:LSE VanEck Genomics and Healt.. 9.16 % 0.00 %

+0.21 (+1.41%)

USD 6.97M
IBBQ Invesco Nasdaq Biotechnol.. 8.68 % 0.00 %

+0.39 (+1.41%)

USD 0.04B
EMEH:SW BNP Paribas Easy Energy &.. 8.55 % 0.00 %

N/A

N/A
2B70:F iShares NASDAQ US Biotech.. 8.52 % 0.00 %

N/A

USD 0.52B
2B70:XETRA iShares Nasdaq US Biotech.. 8.52 % 0.00 %

+0.07 (+1.41%)

USD 0.52B
CURE:XETRA VanEck Genomics and Healt.. 8.30 % 0.00 %

+0.28 (+1.41%)

N/A
BTEC:SW iShares Nasdaq US Biotech.. 8.28 % 0.00 %

+0.11 (+1.41%)

N/A
HHL-U:CA Harvest Healthcare Leader.. 4.97 % 0.00 %

N/A

N/A
HHL-B:CA Harvest Healthcare Leader.. 4.97 % 0.00 %

+0.05 (+1.41%)

N/A
SPQH:XETRA Global X S&P 500® Quarte.. 4.95 % 0.00 %

+0.08 (+1.41%)

USD 0.12B
PINK Simplify Exchange Traded .. 4.85 % 0.00 %

+0.29 (+1.41%)

USD 0.25B
ZWHC:CA BMO Covered Call Health C.. 4.73 % 0.00 %

N/A

N/A
UBIO 4.54 % 0.95 %

N/A

N/A
EGUSAS:SW UBS (Irl) Fund Solutions .. 4.35 % 0.00 %

N/A

USD 0.08B
MEDX Horizon Kinetics Medical .. 4.26 % 0.00 %

+0.18 (+1.41%)

N/A
XDNA:CA iShares Genomics Immunolo.. 4.25 % 0.00 %

N/A

CAD 4.99M
SYNB Putnam Biorevolution ETF 4.03 % 0.00 %

+0.24 (+1.41%)

USD 5.43M
STNC Stance Equity ESG Large C.. 4.01 % 0.00 %

+0.20 (+1.41%)

USD 0.10B
HEAL:CA 3.97 % 0.00 %

N/A

N/A
FDG American Century ETF Trus.. 3.60 % 0.00 %

+0.44 (+1.41%)

N/A
KONG Formidable Fortress ETF 3.46 % 0.00 %

+0.17 (+1.41%)

USD 0.02B
AGNG Global X Aging Population.. 3.40 % 0.00 %

+0.12 (+1.41%)

USD 0.06B
CURE:AU ETFS S&P Biotech ETF 2.60 % 0.00 %

-0.36 (1.41%)

USD 0.04B
CGGR Capital Group Growth ETF 2.54 % 0.00 %

+0.26 (+1.41%)

USD 6.70B
CAPS:LSE First Trust Capital Stren.. 2.26 % 0.00 %

+19.25 (+1.41%)

N/A
TDOC:CA TD Global Healthcare Lead.. 2.17 % 0.00 %

+0.09 (+1.41%)

CAD 0.09B
PFUT Putnam Sustainable Future.. 2.13 % 0.00 %

+0.16 (+1.41%)

USD 0.27B
FTCS:LSE First Trust Capital Stren.. 2.10 % 0.00 %

+0.49 (+1.41%)

USD 0.01B
HTEC Robo Global® Healthcare .. 1.87 % 0.00 %

+0.32 (+1.41%)

USD 0.06B
XLVE:CA Mulvihill U.S. Health Car.. 1.84 % 0.00 %

N/A

N/A
DOCG:LSE L&G Healthcare Breakthrou.. 1.82 % 0.00 %

+6.50 (+1.41%)

USD 0.07B
DOCT:LSE L&G Healthcare Breakthrou.. 1.82 % 0.00 %

+0.23 (+1.41%)

USD 0.07B
JEPI JPMorgan Equity Premium I.. 1.40 % 0.00 %

+0.33 (+1.41%)

USD 34.45B
FLXU:LSE Franklin LibertyQ U.S. Eq.. 1.13 % 0.00 %

+0.40 (+1.41%)

USD 0.09B
FRUE:LSE Franklin LibertyQ U.S. Eq.. 1.13 % 0.00 %

+0.84 (+1.41%)

USD 0.09B
FLXU:XETRA Franklin LibertyShares IC.. 1.07 % 0.00 %

+0.52 (+1.41%)

USD 0.18B
TPLC Timothy Plan US Large/Mid.. 0.62 % 0.00 %

+0.47 (+1.41%)

USD 0.25B
TPLE Timothy Plan - Timothy Pl.. 0.61 % 0.00 %

+0.26 (+1.41%)

USD 0.07B
SMRT:PA 0.56 % 0.00 %

N/A

N/A
ACWV 0.00 % 0.20 %

N/A

N/A
BBH VanEck Biotech ETF 0.00 % 0.35 %

+1.73 (+1.41%)

USD 0.45B
BIB ProShares Ultra Nasdaq Bi.. 0.00 % 0.95 %

+2.09 (+1.41%)

USD 0.09B
BIS ProShares UltraShort Nasd.. 0.00 % 0.95 %

-0.46 (1.41%)

USD 3.31M
FBT First Trust NYSE Arca Bio.. 0.00 % 0.57 %

+2.51 (+1.41%)

N/A
FPX First Trust US Equity Opp.. 0.00 % 0.59 %

+1.47 (+1.41%)

N/A
FTCS First Trust Capital Stren.. 0.00 % 0.60 %

+0.54 (+1.41%)

USD 9.03B
IBB iShares Biotechnology ETF 0.00 % 0.47 %

+2.25 (+1.41%)

USD 7.71B
LABD Direxion Daily S&P Biotec.. 0.00 % 1.00 %

-0.37 (1.41%)

USD 0.09B
LABU Direxion Daily S&P Biotec.. 0.00 % 1.14 %

+8.40 (+1.41%)

USD 0.94B
PBE Invesco Dynamic Biotechno.. 0.00 % 0.57 %

+1.20 (+1.41%)

N/A
PJP Invesco Dynamic Pharmaceu.. 0.00 % 0.56 %

+0.85 (+1.41%)

N/A
PTH Invesco DWA Healthcare Mo.. 0.00 % 0.60 %

+0.98 (+1.41%)

USD 0.14B
PXLG Invesco S&P 500 GARP ETF 0.00 % 0.39 %

+1.26 (+1.41%)

N/A
QQQE Direxion NASDAQ-100 Equal.. 0.00 % 0.35 %

+0.63 (+1.41%)

USD 1.21B
ULVM VictoryShares US Value Mo.. 0.00 % 0.20 %

+0.81 (+1.41%)

USD 0.16B
FTXH First Trust Nasdaq Pharma.. 0.00 % 0.60 %

+0.20 (+1.41%)

USD 0.02B
PVAL Putnam Focused Large Cap .. 0.00 % 0.29 %

+0.32 (+1.41%)

USD 1.03B
HERS-B:CA 0.00 % 0.00 %

N/A

N/A
BTEC:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

+0.12 (+1.41%)

N/A
BTEK:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

+0.06 (+1.41%)

N/A
BIOT:LSE L&G PHARMA BREAKTHROUGH G.. 0.00 % 0.00 %

+0.10 (+1.41%)

N/A
BTEE:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

+0.11 (+1.41%)

N/A
XBI SPDR® S&P Biotech ETF 0.00 % 0.35 %

+2.15 (+1.41%)

N/A
XMW:CA iShares MSCI Min Vol Glob.. 0.00 % 0.48 %

+0.40 (+1.41%)

CAD 0.18B
XMY:CA iShares MSCI Min Vol Glob.. 0.00 % 0.48 %

N/A

N/A
ZBIO 0.00 % 0.95 %

N/A

N/A
HHL:CA Harvest Healthcare Leader.. 0.00 % 1.15 %

N/A

N/A
HERS:CA 0.00 % 0.62 %

N/A

N/A
ENTR ERShares Entrepreneurs ET.. 0.00 % 0.49 %

N/A

USD 0.08B
FPX:LSE First Trust Global Funds .. 0.00 % 0.00 %

+54.00 (+1.41%)

N/A
SMRG:LSE 0.00 % 0.00 %

N/A

N/A
SMRU:LSE Amundi Index Solutions - .. 0.00 % 0.00 %

+8.23 (+1.41%)

N/A
VMOM:LSE 0.00 % 0.00 %

N/A

N/A
EMEH:F BNP Paribas Easy Energy &.. 0.00 % 0.00 %

+0.13 (+1.41%)

N/A
GSDE:F BNP Paribas Easy Energy &.. 0.00 % 0.00 %

+0.09 (+1.41%)

N/A
SM8T:F Amundi Index Solutions - .. 0.00 % 0.00 %

+2.40 (+1.41%)

N/A
SM8T:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

+6.50 (+1.41%)

USD 0.04B
XMLH:XETRA L&G Healthcare Breakthrou.. 0.00 % 0.00 %

+0.12 (+1.41%)

USD 0.07B
BIOT 0.00 % 0.00 %

N/A

N/A
NVQ 0.00 % 0.00 %

N/A

N/A
DWEQ 0.00 % 0.00 %

N/A

N/A
LYFE 0.00 % 0.00 %

N/A

N/A
SMRU:PA Amundi Index Solutions - .. 0.00 % 0.00 %

+8.07 (+1.41%)

USD 3.48M
XMLH:F Legal & General Ucits Etf.. 0.00 % 0.00 %

-0.06 (1.41%)

USD 0.07B
DOCT:SW L&G Healthcare Breakthrou.. 0.00 % 0.00 %

+0.11 (+1.41%)

USD 0.07B

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 36.41% 78% C+ 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 36.41% 78% C+ 87% B+
Trailing 12 Months  
Capital Gain 43.64% 79% B- 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 43.64% 79% B- 86% B+
Trailing 5 Years  
Capital Gain 313.49% 93% A 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 313.49% 93% A 94% A
Average Annual (5 Year Horizon)  
Capital Gain 22.86% 75% C 80% B-
Dividend Return 22.86% 75% C 80% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 23.63% 95% A 71% C-
Risk Adjusted Return 96.77% 100% F 96% N/A
Market Capitalization 42.08B 100% F 99% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Biotechnology) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 60.10 22% 30%
Price/Book Ratio 4.69 28% 24%
Price / Cash Flow Ratio 28.78 3% 10%
Price/Free Cash Flow Ratio 24.49 3% 13%
Management Effectiveness  
Return on Equity 16.55% 97% 87%
Return on Invested Capital 14.45% 88% 84%
Return on Assets 7.62% 97% 92%
Debt to Equity Ratio 7.63% 60% 75%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.